Search - tctmd.com

Displaying 1 - 20 of 1209

Sort: Relevancy | Date

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

News Conference News ACC 2026

Clinician EHR Alerts Lead to Speedier Evaluation, Treatment of Valve Disease

April 01, 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

News Conference News ACC 2026

Transcatheter ViV a Solid Option for Failed Mitral Bioprostheses: SURViV

March 30, 2026

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

News Daily News

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

Michael O'Riordan

March 27, 2026

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

News Daily News

FDA Approves JenaValve’s Trilogy for Aortic Regurgitation

Michael O'Riordan

March 23, 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

March 04, 2026

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

Meta-analysis Teases Out What Drives Success in M-TEER

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

February 10, 2026

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

News Daily News

Year in Review: Structural Heart in 2025 Features EARLY TAVR, Tricuspid Nuance, Mitral Gains

December 31, 2025

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

October 27, 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

October 27, 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

October 25, 2025

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

October 22, 2025

SAVR Bests TAVI in Patients With Highly Calcific Aortic Valves

News Conference News EACTS 2025

SAVR Bests TAVI in Patients With Highly Calcific Aortic Valves

Yael L. Maxwell

October 20, 2025

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

News Daily News

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

October 14, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.